genitourinary disorders
Membranoproliferative Glomerulonephritis
Treatment of Membranoproliferative Glomerulonephritis
Corticosteroids for children with nephrotic-range proteinuria Kidney transplantation for patients with Chronic Kidney Disease None Underlying disorders are treated when possible. Patients with mild disease (ie, normal kidney function and non–nephrotic-range proteinuria or significant hematuria) are typically treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). Additional immunosuppressive therapy is typically not indicated in such patients. 2.5 mg/kg orally once a day on alternate days [maximum 80 mg/day]) for 1 year, followed by tapering to maintenance therapy may stabilize renal function. However, corticosteroid treatment may retard growth in children and cause Hypertension . Calcineurin inhibitors (eg, Other general supportive measures include dietary and sodium restriction, antihypertensive therapy, renin-angiotensin inhibition, and treatment of dyslipidemia. 